Jonathan Stuart Kaplan

Array ( [id] => 8397944 [patent_doc_number] => 08268323 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Conformationally stabilized HIV envelope immunogens' [patent_app_type] => utility [patent_app_number] => 13/232775 [patent_app_country] => US [patent_app_date] => 2011-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 114344 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13232775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8305710 [patent_doc_number] => 08227243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Settings for recombinant adenoviral-based vaccines' [patent_app_type] => utility [patent_app_number] => 13/199285 [patent_app_country] => US [patent_app_date] => 2011-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 18776 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13199285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656395 [patent_doc_number] => 20110305664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'NOVEL VACCINES AGAINST MULTIPLE SUBTYPES OF INFLUENZA VIRUS' [patent_app_type] => utility [patent_app_number] => 13/158150 [patent_app_country] => US [patent_app_date] => 2011-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13988 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305664.pdf [firstpage_image] =>[orig_patent_app_number] => 13158150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579850 [patent_doc_number] => 20110293733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'SELF-ASSEMBLING NANOPARTICLE DRUG DELIVERY SYSTEM' [patent_app_type] => utility [patent_app_number] => 13/085892 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9313 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293733.pdf [firstpage_image] =>[orig_patent_app_number] => 13085892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174512 [patent_doc_number] => 20110177124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'CODON-OPTIMIZED POLYNUCLEOTIDE-BASED VACCINES AGAINST HUMAN CYTOMEGALOVIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 13/013752 [patent_app_country] => US [patent_app_date] => 2011-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 37673 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177124.pdf [firstpage_image] =>[orig_patent_app_number] => 13013752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144401 [patent_doc_number] => 20110130301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'Settings for recombinant adenoviral-based vaccines' [patent_app_type] => utility [patent_app_number] => 12/930661 [patent_app_country] => US [patent_app_date] => 2011-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 18891 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130301.pdf [firstpage_image] =>[orig_patent_app_number] => 12930661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943497 [patent_doc_number] => 20110104117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'METABOLICALLY ACTIVATED RECOMBINANT VIRAL VECTORS AND METHODS FOR THEIR PREPARATION AND USE' [patent_app_type] => utility [patent_app_number] => 12/910711 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21735 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104117.pdf [firstpage_image] =>[orig_patent_app_number] => 12910711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615997 [patent_doc_number] => 20100323952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'Nucleoside Analogs in Combination Therapy of Herpes Simplex Infections' [patent_app_type] => utility [patent_app_number] => 12/871563 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2099 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323952.pdf [firstpage_image] =>[orig_patent_app_number] => 12871563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328462 [patent_doc_number] => 08236558 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Bovine immunodeficiency virus (BIV) based vectors' [patent_app_type] => utility [patent_app_number] => 12/871902 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17441 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12871902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7977981 [patent_doc_number] => 08071738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Feline CD86 polypeptides and nucleic acids' [patent_app_type] => utility [patent_app_number] => 12/794422 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 40067 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071738.pdf [firstpage_image] =>[orig_patent_app_number] => 12794422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7773538 [patent_doc_number] => 08119339 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Heteroduplex tracking assay' [patent_app_type] => utility [patent_app_number] => 12/723162 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 35836 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119339.pdf [firstpage_image] =>[orig_patent_app_number] => 12723162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958551 [patent_doc_number] => 20110182938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'INFLUENZA NUCLEIC ACID MOLECULES AND VACCINES MADE THEREFROM' [patent_app_type] => utility [patent_app_number] => 12/694238 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16908 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182938.pdf [firstpage_image] =>[orig_patent_app_number] => 12694238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958551 [patent_doc_number] => 20110182938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'INFLUENZA NUCLEIC ACID MOLECULES AND VACCINES MADE THEREFROM' [patent_app_type] => utility [patent_app_number] => 12/694238 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16908 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182938.pdf [firstpage_image] =>[orig_patent_app_number] => 12694238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6575825 [patent_doc_number] => 20100129438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'Methods and Compositions for the Treatment and Prevention of HIV Infection Using TRIM5ALPHA' [patent_app_type] => utility [patent_app_number] => 12/689800 [patent_app_country] => US [patent_app_date] => 2010-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 48217 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129438.pdf [firstpage_image] =>[orig_patent_app_number] => 12689800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6608567 [patent_doc_number] => 20100099188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'Dual Inhibitors of HIV-1 gp-120 Interactions' [patent_app_type] => utility [patent_app_number] => 12/638725 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1701 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099188.pdf [firstpage_image] =>[orig_patent_app_number] => 12638725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6529181 [patent_doc_number] => 20100015176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Settings for recombinant adenoviral-based vaccines' [patent_app_type] => utility [patent_app_number] => 12/583628 [patent_app_country] => US [patent_app_date] => 2009-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 18938 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015176.pdf [firstpage_image] =>[orig_patent_app_number] => 12583628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280571 [patent_doc_number] => 20100119536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Naturally Processed Measles Virus Peptides From Class II HLA Molecules' [patent_app_type] => utility [patent_app_number] => 12/507163 [patent_app_country] => US [patent_app_date] => 2009-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 27514 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119536.pdf [firstpage_image] =>[orig_patent_app_number] => 12507163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4555439 [patent_doc_number] => 07842298 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-30 [patent_title] => 'Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E' [patent_app_type] => utility [patent_app_number] => 12/507576 [patent_app_country] => US [patent_app_date] => 2009-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 42 [patent_no_of_words] => 20651 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/842/07842298.pdf [firstpage_image] =>[orig_patent_app_number] => 12507576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6535482 [patent_doc_number] => 20100015596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'RS VIRUS DETECTING KIT USING ANTI-RS VIRUS MONOCLONAL ANTIBODY, IMMUNO-CHROMATOGRAPHIC TEST DEVICE, AND NEW ANTI-RS VIRUS MONOCLONAL ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/505144 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9715 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015596.pdf [firstpage_image] =>[orig_patent_app_number] => 12505144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6485430 [patent_doc_number] => 20100285457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'High-Throughput Diagnostic Assay For the Human Virus Causing Severe Acute Respiratory Syndrome (SARS)' [patent_app_type] => utility [patent_app_number] => 12/483301 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 111 [patent_figures_cnt] => 111 [patent_no_of_words] => 33933 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12483301 [rel_patent_id] =>[rel_patent_doc_number] =>)